GnRH agonist pretreatment prior to frozen embryo transfer in women with adenomyosis: a systematic review and meta-analysis.

Steinmann, Marcel, Anthon, Christiane, Kohl Schwartz, Alexandra S., Mackens, Shari, Blockeel, Christophe, Kalaitzopoulos, Dimitrios R., Vidal, Angela
2025 · doi:10.48620/91854 · W7091691639
article OA: green CC0
🔓 Open OA copy Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-30 ⓘ

A meta-analysis of seven retrospective cohorts and one randomized trial found that GnRHa pretreatment does not significantly improve live birth, clinical pregnancy, miscarriage, or implantation rates compared to hormone replacement therapy alone in women with adenomyosis undergoing frozen embryo transfer.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-10 · read from full text ⓘ

I can’t access the actual paper content because the provided text is blocked by a website anti-bot mechanism, so I’m unable to identify the study population, methods, outcomes, or results from the systematic review and meta-analysis. Without the full text, I also can’t report the limitations that the authors explicitly state. The paper title indicates it evaluates whether GnRH agonist pretreatment before frozen embryo transfer affects outcomes in women with adenomyosis. This paper is centrally about adenomyosis — it focuses specifically on GnRH agonist pretreatment prior to frozen embryo transfer.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The aim of this study was to investigate whether gonadotrophin-releasing hormone agonist (GnRHa) pretreatment has a positive effect on pregnancy outcomes in women with adenomyosis who were undergoing a frozen embryo transfer (FET) cycle. A systematic search of the PubMed, Embase and Cochrane databases up to 20 March 2025 was conducted. The primary outcome was live birth rate, while secondary outcomes were the clinical pregnancy, implantation and miscarriage rates. Seven retrospective cohort studies and one randomized trial met the inclusion criteria. The meta-analysis of studies comparing GnRHa pretreatment plus hormone replacement therapy (HRT)-FET with HRT-FET alone in women with adenomyosis showed a comparable live birth rate (six studies, odds ratio [OR] 1.19, 95% CI 0.69-2.06, I2 = 74%), clinical pregnancy rate (seven studies, OR 1.36, 95% CI 0.83-2.23, I2 = 80%), miscarriage rate (six studies, OR 1.09, 95% CI 0.69-1.74, I2 = 20%) and implantation rate per embryo transfer (three studies, OR 1.38, 95% CI 0.59-3.24, I2 = 90%). Current evidence does not demonstrate the superiority of GnRHa pretreatment plus HRT over HRT alone in women with adenomyosis prior to FET. Future randomized trials are needed to determine the optimal protocol for FET in this population.
Full text 1,068 characters · extracted from oa-html · click to expand
Making sure you're not a bot! Loading... You are seeing this because the administrator of this website has set up Anubis to protect the server against the scourge of AI companies aggressively scraping websites. This can and does cause downtime for the websites, which makes their resources inaccessible for everyone. Anubis is a compromise. Anubis uses a Proof-of-Work scheme in the vein of Hashcash, a proposed proof-of-work scheme for reducing email spam. The idea is that at individual scales the additional load is ignorable, but at mass scraper levels it adds up and makes scraping much more expensive. Ultimately, this is a placeholder solution so that more time can be spent on fingerprinting and identifying headless browsers (EG: via how they do font rendering) so that the challenge proof of work page doesn't need to be presented to users that are much more likely to be legitimate. Please note that Anubis requires the use of modern JavaScript features that plugins like JShelter will disable. Please disable JShelter or other such plugins for this domain.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-05-10T10:22:15.819317+00:00
License: CC0 · commercial use OK